On June 13, Immunomic Therapeutics Inc. (ITI) participated in the “Making a Name in Cancer Immunotherapy” webcast, hosted by Nature.com. Other participating companies included Isoplexis, Merus, and Actinium Pharmaceuticals, Inc. The webcast covered several new and advanced approaches to immunotherapy and featured our very own LAMP-Vax™ technology.
If you missed the webcast and would like to hear more about our recent advancements in technology head to http://bit.ly/2skLnhY to register. Upon registering, you will have immediate, on-demand access to the webcast. Our segment, presented by Sia Anagnostou, Immunomic’s Senior Director of Corporate Development, is first up in the webcast (beginning at 1:15). If you have any questions, please feel free to contact us at info@immunomix.com.